GTAC advises on x-SCID gene therapy
Bulletin of Medical Ethics 2002 October; (182): 5-6
Showing items related by title, author, creator and subject.
French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy European Society of Gene Therapy [ESGT] (2003-01)
Calculating risk/benefit in X-linked severe combined immune defieciency disorder (X-SCID) gene therapy trials: the task of ethical evaluation Swazo, Norman K. (2006-10)In response to adverse events in retroviral gene therapy clinical trials conducted in France to correct for X-linked severe combined immune deficiency disorder (X-SCID), an advisory committee of the Food and Drug Administration ...